Family-based and Adolescent Residential Drug Treatment

NCT01737632 | Completed

• 1 other identifier: P50DA011328
• Study Type: interventional
• Target: 113
• Locations: 1 country
• Sites: 2

Brief Summary

The fundamental objective of this study is to compare the effectiveness of an intensive in-home family-based treatment, Multidimensional Family Therapy, with a multifaceted residential treatment, Adolescent Residential Treatment, over 4 years post-intake and to delineate the mechanisms of change for each treatment. The study targets dually- diagnosed adolescent drug abusers recommended for residential treatment.

Conditions

Substance Use; Delinquency

Keywords

Adolescents; Residential Treatment; Outpatient Treatment; Substance Abuse; Delinquency; Family Therapy; Multidimensional Family therapy

Outcome Measures

Primary Outcomes (5)

• Change in Personal Involvement with Chemicals

  Scale from the Personal Experience Inventory (PEI) developed by Ken Winter.

  Baseline, 2, 4, 12, 18, 24, 36 and 48 months after baseline

• Change in substance use consumption

  Measure of substance use consumption as measured by the Timeline Follow-back Method.

  Baseline, 2, 4, 12,18,24,36,48 months after intake

• Change in externalizing symptoms

  Externalizing symptoms measured by the Youth Self Report

  Baseline, 2, 4, 12, 18, 24, 36 and 48 months

• Change in delinquency

  Measured by youth report on the Self Report Delinquency Scale.

  Intake, 2, 4, 12, 18, 24, 35, 48 months after intake

• Change in internalzing symptoms

  Measured by the Youth Self Report (YSR)

  Intake, 2, 4, 12, 18, 24, 36, 48 months after baseline

Secondary Outcomes (3)

• Change in family conflict

  Baseline, 2, 4, 12, 18, 24, 36, 48 months after baseline

• Change in parenting practices

  Baseline, 2, 4, 12, 18, 24,36, 48 months after baseline

• Change in family cohesion

  Intake, 2, 4, 12, 18, 24, 26, 48 months after intake

Study Arms (2)

Multidimensional Family Therapy (MDFT)

EXPERIMENTAL

MDFT is an intensive, in-home family-based drug abuse treatment for adolescent substance abusers. MDFT views family factors in their context -in terms of the network (individual, familial, peer, community) or multiplicity of influences on drug use and change.

Behavioral: Multidimensional Family Therapy (MDFT)

Adolescent Residential Treatment

OTHER

The Adolescent Treatment Program (ATP) is a residential dual diagnosed substance abuse treatment program that is staff secure. It is based on a social learning approach which emphasizes positive reinforcement for appropriate coping behavior and social skills, and incorporates a "levels" system which allocates privileges and responsibilities according to the individual's behavioral capacities.

Behavioral: Adolescent Residential Treatment

Interventions

Multidimensional Family Therapy (MDFT) BEHAVIORAL

MDFT assesses and intervenes in five domains: 1) Interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.

Multidimensional Family Therapy (MDFT)

Adolescent Residential Treatment BEHAVIORAL

The Adolescent Treatment Program targets the adolescent's abuse or dependency on chemicals while simultaneously treating the comorbid symptomatology found in dual diagnosed patients. These goals are accomplished by using four primary forms of intervention: (1) Chemical Education; (2) Group, Individual and Family Counseling; (3) Twelve Step Work; and 4) Psychotropic Medication for Clinical Symptomatology Comorbid with Substance Abuse.

Adolescent Residential Treatment

Eligibility Criteria

• Age: 13 Years - 17 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Youth between the ages of 13 and 17
• Referred to ATP for residential substance abuse treatment in youth dual diagnosis program
• Dually diagnosed for substance abuse or dependence and at least one of the following co-morbid conditions: major depressive disorder, bipolar disorder, I conduct disorder, oppositional defiant disorder,
• At least one parent or parent-figure can be located at the time of referral.
• Obtain informed consent from a parent or formal guardian and assent from youth to participate in the study.

You may not qualify if:

• Have any of the following disorders: Mental Retardation, Eating Disorders, Schizophrenia, or Pervasive Developmental Disorders.
• Current suicidality.

Sponsors & Collaborators

• University of Miami: lead

Study Sites (2)

University of Miami Miller School of Medicine

Miami, Florida, 33136, United States

Location

The Village, Inc.

Miami, Florida, 33137, United States

Location

Related Publications (1)

• Zavala SK, French MT, Henderson CE, Alberga L, Rowe C, Liddle HA. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments. J Subst Abuse Treat. 2005 Oct;29(3):191-205. doi: 10.1016/j.jsat.2005.06.004.

  PMID: 16183468 BACKGROUND

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Howard A Liddle, EdD

  University of Miami

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: November 20, 2012
• First Posted: November 29, 2012
• Study Start: August 1, 2000
• Primary Completion: June 1, 2008
• Study Completion: June 1, 2010
• Last Updated: November 29, 2012

Record last verified: 2012-11

Locations

US (2)